Follow the people · Insider
Michael R. Megna
Michael R. Megna files insider transactions with the SEC as a chief accounting officer of Kiniksa Pharmaceuticals (KNSA). We hold 2 disclosed purchases and sales filed since 26 February 2010, 1 of them in the last 90 days.
- Files forKNSA
- Disclosed buys and sells2 in all, 1 in the last 90 days
- Last disclosure3 September 2026
Positions held
2 posts we hold — a term names its own dates; a run of filings only says when they filed- Filed 13 March 2020 — 3 September 2026Chief Accounting Officer · Kiniksa Pharmaceuticals (KNSA)188 Form 4 lines · source: SEC Form 4
- Filed 24 February 2010 — 10 September 2010Chief Accounting Officer · Biosphere Medical (BSMD)5 Form 4 lines · source: SEC Form 4
Everything they disclosed
120 entries, newest first — one per disclosure report, one per Form 4 line- was granted 279 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2026Class A Ordinary Share · traded 15 July 2026 · filed 3 September 2026
- exercised options over 2,644 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2026Restricted Share Unit · traded 1 September 2026 · filed 3 September 2026
- exercised options over 2,362 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2026Restricted Share Unit · traded 1 September 2026 · filed 3 September 2026
- exercised options over 2,558 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2026Restricted Share Unit · traded 1 September 2026 · filed 3 September 2026
- exercised options over 3,932 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2026Restricted Share Unit · traded 1 September 2026 · filed 3 September 2026
- exercised options over 3,932 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2026Class A Ordinary Share · traded 1 September 2026 · filed 3 September 2026
- exercised options over 2,558 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2026Class A Ordinary Share · traded 1 September 2026 · filed 3 September 2026
- exercised options over 2,362 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2026Class A Ordinary Share · traded 1 September 2026 · filed 3 September 2026
- exercised options over 2,644 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2026Class A Ordinary Share · traded 1 September 2026 · filed 3 September 2026
- had shares withheld for tax on 5,531 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2026Class A Ordinary Share · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 4,600 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2026Class A Ordinary Share · traded 3 September 2026 · filed 3 September 2026
- was granted 3,650 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2026Restricted Share Unit · traded 1 September 2026 · filed 3 September 2026
- was granted 14,600 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2026Share Option · traded 1 September 2026 · filed 3 September 2026
- ▼ sold on the open market 6,625 shares of Kiniksa Pharmaceuticals InternationalSEC Form 413 April 2026Class A Ordinary Share · traded 9 April 2026 · filed 13 April 2026
- exercised options over 3,932 shares of Kiniksa Pharmaceuticals InternationalSEC Form 48 April 2026Class A Ordinary Share · traded 7 April 2026 · filed 8 April 2026
- had shares withheld for tax on 1,666 shares of Kiniksa Pharmaceuticals InternationalSEC Form 48 April 2026Class A Ordinary Share · traded 7 April 2026 · filed 8 April 2026
- exercised options over 3,932 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 48 April 2026Restricted Share Unit · traded 7 April 2026 · filed 8 April 2026
- was granted 372 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 April 2026Class A Ordinary Share · traded 15 January 2026 · filed 3 April 2026
- exercised options over 7,564 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 April 2026Class A Ordinary Share · traded 1 April 2026 · filed 3 April 2026
- had shares withheld for tax on 3,205 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 April 2026Class A Ordinary Share · traded 1 April 2026 · filed 3 April 2026
- was granted 14,600 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2026Share Option · traded 1 April 2026 · filed 3 April 2026
- was granted 3,650 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2026Restricted Share Unit · traded 1 April 2026 · filed 3 April 2026
- was granted 7,300 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2026Performance Share Unit · traded 1 April 2026 · filed 3 April 2026
- exercised options over 2,558 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2026Restricted Share Unit · traded 1 April 2026 · filed 3 April 2026
- exercised options over 2,362 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2026Restricted Share Unit · traded 1 April 2026 · filed 3 April 2026
- exercised options over 2,644 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2026Restricted Share Unit · traded 1 April 2026 · filed 3 April 2026
- exercised options over 791 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 422 October 2025Share Option · traded 20 October 2025 · filed 22 October 2025
- exercised options over 6,195 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 422 October 2025Share Option · traded 20 October 2025 · filed 22 October 2025
- exercised options over 9,831 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 422 October 2025Share Option · traded 20 October 2025 · filed 22 October 2025
- exercised options over 9,831 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 422 October 2025Share Option · traded 20 October 2025 · filed 22 October 2025
- exercised options over 12,787 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 422 October 2025Share Option · traded 20 October 2025 · filed 22 October 2025
- exercised options over 791 shares of Kiniksa Pharmaceuticals InternationalSEC Form 422 October 2025Class A Ordinary Share · traded 20 October 2025 · filed 22 October 2025
- exercised options over 6,195 shares of Kiniksa Pharmaceuticals InternationalSEC Form 422 October 2025Class A Ordinary Share · traded 20 October 2025 · filed 22 October 2025
- exercised options over 9,831 shares of Kiniksa Pharmaceuticals InternationalSEC Form 422 October 2025Class A Ordinary Share · traded 20 October 2025 · filed 22 October 2025
- exercised options over 9,831 shares of Kiniksa Pharmaceuticals InternationalSEC Form 422 October 2025Class A Ordinary Share · traded 20 October 2025 · filed 22 October 2025
- exercised options over 12,787 shares of Kiniksa Pharmaceuticals InternationalSEC Form 422 October 2025Class A Ordinary Share · traded 20 October 2025 · filed 22 October 2025
- ▼ sold on the open market 37,255 shares of Kiniksa Pharmaceuticals InternationalSEC Form 422 October 2025Class A Ordinary Share · traded 20 October 2025 · filed 22 October 2025
- ▼ sold on the open market 13,235 shares of Kiniksa Pharmaceuticals InternationalSEC Form 422 October 2025Class A Ordinary Share · traded 20 October 2025 · filed 22 October 2025
- exercised options over 175 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 48 October 2025Restricted Share Unit · traded 4 October 2025 · filed 8 October 2025
- exercised options over 175 shares of Kiniksa Pharmaceuticals InternationalSEC Form 48 October 2025Class A Ordinary Share · traded 4 October 2025 · filed 8 October 2025
- had shares withheld for tax on 85 shares of Kiniksa Pharmaceuticals InternationalSEC Form 48 October 2025Class A Ordinary Share · traded 4 October 2025 · filed 8 October 2025
- was granted 10,575 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2025Restricted Share Unit · traded 1 September 2025 · filed 3 September 2025
- was granted 21,150 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2025Share Option · traded 1 September 2025 · filed 3 September 2025
- exercised options over 2,363 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2025Restricted Share Unit · traded 1 September 2025 · filed 3 September 2025
- exercised options over 2,557 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2025Restricted Share Unit · traded 1 September 2025 · filed 3 September 2025
- exercised options over 3,933 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2025Restricted Share Unit · traded 1 September 2025 · filed 3 September 2025
- exercised options over 774 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2025Restricted Share Unit · traded 2 September 2025 · filed 3 September 2025
- exercised options over 11,000 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 September 2025Share Option · traded 3 September 2025 · filed 3 September 2025
- exercised options over 2,363 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2025Class A Ordinary Share · traded 1 September 2025 · filed 3 September 2025
- exercised options over 2,557 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2025Class A Ordinary Share · traded 1 September 2025 · filed 3 September 2025
- exercised options over 3,933 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2025Class A Ordinary Share · traded 1 September 2025 · filed 3 September 2025
- had shares withheld for tax on 4,282 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2025Class A Ordinary Share · traded 1 September 2025 · filed 3 September 2025
- exercised options over 774 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2025Class A Ordinary Share · traded 2 September 2025 · filed 3 September 2025
- had shares withheld for tax on 375 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2025Class A Ordinary Share · traded 2 September 2025 · filed 3 September 2025
- exercised options over 11,000 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2025Class A Ordinary Share · traded 3 September 2025 · filed 3 September 2025
- ▼ sold on the open market 11,000 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 September 2025Class A Ordinary Share · traded 3 September 2025 · filed 3 September 2025
- exercised options over 17,000 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 46 August 2025Share Option · traded 4 August 2025 · filed 6 August 2025
- was granted 495 shares of Kiniksa Pharmaceuticals InternationalSEC Form 46 August 2025Class A Ordinary Share · traded 15 July 2025 · filed 6 August 2025
- exercised options over 17,000 shares of Kiniksa Pharmaceuticals InternationalSEC Form 46 August 2025Class A Ordinary Share · traded 4 August 2025 · filed 6 August 2025
- ▼ sold on the open market 17,000 shares of Kiniksa Pharmaceuticals InternationalSEC Form 46 August 2025Class A Ordinary Share · traded 4 August 2025 · filed 6 August 2025
- exercised options over 15,211 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 45 June 2025Share Option · traded 3 June 2025 · filed 5 June 2025
- exercised options over 15,211 shares of Kiniksa Pharmaceuticals InternationalSEC Form 45 June 2025Class A Ordinary Share · traded 3 June 2025 · filed 5 June 2025
- ▼ sold on the open market 15,211 shares of Kiniksa Pharmaceuticals InternationalSEC Form 45 June 2025Class A Ordinary Share · traded 3 June 2025 · filed 5 June 2025
- exercised options over 229 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 49 May 2025Share Option · traded 7 May 2025 · filed 9 May 2025
- exercised options over 2,998 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 49 May 2025Share Option · traded 7 May 2025 · filed 9 May 2025
- exercised options over 14,420 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 49 May 2025Share Option · traded 7 May 2025 · filed 9 May 2025
- exercised options over 229 shares of Kiniksa Pharmaceuticals InternationalSEC Form 49 May 2025Class A Ordinary Share · traded 7 May 2025 · filed 9 May 2025
- exercised options over 2,998 shares of Kiniksa Pharmaceuticals InternationalSEC Form 49 May 2025Class A Ordinary Share · traded 7 May 2025 · filed 9 May 2025
- exercised options over 14,420 shares of Kiniksa Pharmaceuticals InternationalSEC Form 49 May 2025Class A Ordinary Share · traded 7 May 2025 · filed 9 May 2025
- ▼ sold on the open market 17,647 shares of Kiniksa Pharmaceuticals InternationalSEC Form 49 May 2025Class A Ordinary Share · traded 7 May 2025 · filed 9 May 2025
- was granted 3,270 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 45 May 2025Performance Share Unit · traded 1 May 2025 · filed 5 May 2025
- was granted 3,433 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 45 May 2025Performance Share Unit · traded 1 May 2025 · filed 5 May 2025
- was granted 5,285 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 45 May 2025Performance Share Option · traded 1 May 2025 · filed 5 May 2025
- was granted 5,456 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 45 May 2025Performance Share Option · traded 1 May 2025 · filed 5 May 2025
- exercised options over 3,933 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 49 April 2025Restricted Share Unit · traded 7 April 2025 · filed 9 April 2025
- exercised options over 3,933 shares of Kiniksa Pharmaceuticals InternationalSEC Form 49 April 2025Class A Ordinary Share · traded 7 April 2025 · filed 9 April 2025
- had shares withheld for tax on 1,666 shares of Kiniksa Pharmaceuticals InternationalSEC Form 49 April 2025Class A Ordinary Share · traded 7 April 2025 · filed 9 April 2025
- was granted 21,150 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2025Share Option · traded 1 April 2025 · filed 3 April 2025
- was granted 10,575 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2025Restricted Share Unit · traded 1 April 2025 · filed 3 April 2025
- exercised options over 2,557 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2025Restricted Share Unit · traded 1 April 2025 · filed 3 April 2025
- exercised options over 2,363 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 43 April 2025Restricted Share Unit · traded 1 April 2025 · filed 3 April 2025
- exercised options over 2,557 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 April 2025Class A Ordinary Share · traded 1 April 2025 · filed 3 April 2025
- exercised options over 2,363 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 April 2025Class A Ordinary Share · traded 1 April 2025 · filed 3 April 2025
- had shares withheld for tax on 1,083 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 April 2025Class A Ordinary Share · traded 1 April 2025 · filed 3 April 2025
- had shares withheld for tax on 1,001 shares of Kiniksa Pharmaceuticals InternationalSEC Form 43 April 2025Class A Ordinary Share · traded 1 April 2025 · filed 3 April 2025
- exercised options over 774 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 419 March 2025Restricted Share Unit · traded 16 March 2025 · filed 19 March 2025
- was granted 469 shares of Kiniksa Pharmaceuticals InternationalSEC Form 419 March 2025Class A Ordinary Share · traded 15 January 2025 · filed 19 March 2025
- exercised options over 774 shares of Kiniksa Pharmaceuticals InternationalSEC Form 419 March 2025Class A Ordinary Share · traded 16 March 2025 · filed 19 March 2025
- had shares withheld for tax on 328 shares of Kiniksa Pharmaceuticals InternationalSEC Form 419 March 2025Class A Ordinary Share · traded 16 March 2025 · filed 19 March 2025
- exercised options over 9,051 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 414 March 2025Share Option · traded 12 March 2025 · filed 14 March 2025
- exercised options over 9,051 shares of Kiniksa Pharmaceuticals InternationalSEC Form 414 March 2025Class A Ordinary Share · traded 12 March 2025 · filed 14 March 2025
- ▼ sold on the open market 9,051 shares of Kiniksa Pharmaceuticals InternationalSEC Form 414 March 2025Class A Ordinary Share · traded 12 March 2025 · filed 14 March 2025
- exercised options over 8,637 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 42 December 2024Share Option · traded 27 November 2024 · filed 2 December 2024
- exercised options over 9 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 42 December 2024Share Option · traded 29 November 2024 · filed 2 December 2024
- exercised options over 8,637 shares of Kiniksa Pharmaceuticals InternationalSEC Form 42 December 2024Class A Ordinary Share · traded 27 November 2024 · filed 2 December 2024
- ▼ sold on the open market 8,637 shares of Kiniksa Pharmaceuticals InternationalSEC Form 42 December 2024Class A Ordinary Share · traded 27 November 2024 · filed 2 December 2024
- exercised options over 9 shares of Kiniksa Pharmaceuticals InternationalSEC Form 42 December 2024Class A Ordinary Share · traded 29 November 2024 · filed 2 December 2024
- ▼ sold on the open market 9 shares of Kiniksa Pharmaceuticals InternationalSEC Form 42 December 2024Class A Ordinary Share · traded 29 November 2024 · filed 2 December 2024
- exercised options over 175 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 48 October 2024Restricted Share Unit · traded 4 October 2024 · filed 8 October 2024
- exercised options over 175 shares of Kiniksa Pharmaceuticals InternationalSEC Form 48 October 2024Class A Ordinary Share · traded 4 October 2024 · filed 8 October 2024
- had shares withheld for tax on 82 shares of Kiniksa Pharmaceuticals InternationalSEC Form 48 October 2024Class A Ordinary Share · traded 4 October 2024 · filed 8 October 2024
- was granted 9,450 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 44 September 2024Restricted Share Unit · traded 1 September 2024 · filed 4 September 2024
- was granted 18,900 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 44 September 2024Share Option · traded 1 September 2024 · filed 4 September 2024
- exercised options over 3,932 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 44 September 2024Restricted Share Unit · traded 1 September 2024 · filed 4 September 2024
- exercised options over 2,558 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 44 September 2024Restricted Share Unit · traded 1 September 2024 · filed 4 September 2024
- exercised options over 775 shares of Kiniksa Pharmaceuticals International (a derivative holding)SEC Form 44 September 2024Restricted Share Unit · traded 2 September 2024 · filed 4 September 2024
- was granted 480 shares of Kiniksa Pharmaceuticals InternationalSEC Form 44 September 2024Class A Ordinary Share · traded 15 July 2024 · filed 4 September 2024
- exercised options over 6,490 shares of Kiniksa Pharmaceuticals InternationalSEC Form 44 September 2024Class A Ordinary Share · traded 1 September 2024 · filed 4 September 2024
- had shares withheld for tax on 2,755 shares of Kiniksa Pharmaceuticals InternationalSEC Form 44 September 2024Class A Ordinary Share · traded 1 September 2024 · filed 4 September 2024
- exercised options over 775 shares of Kiniksa Pharmaceuticals InternationalSEC Form 44 September 2024Class A Ordinary Share · traded 2 September 2024 · filed 4 September 2024
- had shares withheld for tax on 329 shares of Kiniksa Pharmaceuticals InternationalSEC Form 44 September 2024Class A Ordinary Share · traded 2 September 2024 · filed 4 September 2024
- was granted 18,900 shares of Kiniksa Pharmaceuticals (a derivative holding)SEC Form 48 April 2024Share Option · traded 4 April 2024 · filed 8 April 2024
- was granted 9,450 shares of Kiniksa Pharmaceuticals (a derivative holding)SEC Form 48 April 2024Restricted Share Unit · traded 4 April 2024 · filed 8 April 2024
- exercised options over 3,932 shares of Kiniksa Pharmaceuticals (a derivative holding)SEC Form 48 April 2024Restricted Share Unit · traded 8 April 2024 · filed 8 April 2024
- exercised options over 3,932 shares of Kiniksa PharmaceuticalsSEC Form 48 April 2024Class A Common Share · traded 8 April 2024 · filed 8 April 2024
- had shares withheld for tax on 1,666 shares of Kiniksa PharmaceuticalsSEC Form 48 April 2024Class A Common Share · traded 8 April 2024 · filed 8 April 2024
- exercised options over 2,558 shares of Kiniksa Pharmaceuticals (a derivative holding)SEC Form 43 April 2024Restricted Share Unit · traded 1 April 2024 · filed 3 April 2024
- exercised options over 2,558 shares of Kiniksa PharmaceuticalsSEC Form 43 April 2024Class A Common Share · traded 1 April 2024 · filed 3 April 2024
- had shares withheld for tax on 1,084 shares of Kiniksa PharmaceuticalsSEC Form 43 April 2024Class A Common Share · traded 1 April 2024 · filed 3 April 2024
- exercised options over 5,126 shares of Kiniksa Pharmaceuticals (a derivative holding)SEC Form 41 March 2024Share Option · traded 28 February 2024 · filed 1 March 2024
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.